Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation
US10870115B2 · kind B2 · utility
2Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 2016 |
| Grant date | Dec 22, 2020 |
| Priority date | — |
| Expiry date | Dec 6, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/96433
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed herein are evacuated blood collection tubes comprising protease inhibitor cocktails in liquid form and uses thereof for assessing features associated with the contact system in a subject, including the endogenous level of contact system activation, the endogenous level of a drug that targets a component of contact system during treatment, and/or the immunogenicity of such a drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.